These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29079835)

  • 21. Plasma procalcitonin is an independent predictor of graft failure late after renal transplantation.
    van Ree RM; de Vries AP; Oterdoom LH; Seelen MA; Gansevoort RT; Schouten JP; Struck J; Navis G; Gans RO; van der Heide JJ; van Son WJ; Bakker SJ
    Transplantation; 2009 Jul; 88(2):279-87. PubMed ID: 19623026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma bilirubin and late graft failure in renal transplant recipients.
    Deetman PE; Zelle DM; Homan van der Heide JJ; Navis GJ; Gans RO; Bakker SJ
    Transpl Int; 2012 Aug; 25(8):876-81. PubMed ID: 22716194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma ADMA associates with all-cause mortality in renal transplant recipients.
    Frenay AR; van den Berg E; de Borst MH; Beckmann B; Tsikas D; Feelisch M; Navis G; Bakker SJ; van Goor H
    Amino Acids; 2015 Sep; 47(9):1941-9. PubMed ID: 26077715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High urinary homoarginine excretion is associated with low rates of all-cause mortality and graft failure in renal transplant recipients.
    Frenay AR; Kayacelebi AA; Beckmann B; Soedamah-Muhtu SS; de Borst MH; van den Berg E; van Goor H; Bakker SJ; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1827-36. PubMed ID: 26142633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous plasma erythropoietin, cardiovascular mortality and all-cause mortality in renal transplant recipients.
    Sinkeler SJ; Zelle DM; Homan van der Heide JJ; Gans RO; Navis G; Bakker SJ
    Am J Transplant; 2012 Feb; 12(2):485-91. PubMed ID: 22054202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome.
    Carvalho LML; Ferreira CN; de Oliveira DKD; Rodrigues KF; Duarte RCF; Teixeira MFA; Xavier LB; Candido AL; Reis FM; Silva IFO; Campos FMF; Gomes KB
    J Assist Reprod Genet; 2017 Dec; 34(12):1691-1698. PubMed ID: 28900795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Malondialdehyde and Risk of New-Onset Diabetes after Transplantation in Renal Transplant Recipients: A Prospective Cohort Study.
    Yepes-Calderón M; Sotomayor CG; Gomes-Neto AW; Gans ROB; Berger SP; Rimbach G; Esatbeyoglu T; Rodrigo R; Geleijnse JM; Navis GJ; Bakker SJL
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30987358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intake of Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Mortality in Renal Transplant Recipients.
    Gomes Neto AW; Sotomayor CG; Pranger IG; van den Berg E; Gans RO; Soedamah-Muthu SS; Navis GJ; Bakker SJ
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28379169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haptoglobin 2-1 phenotype predicts rapid growth of abdominal aortic aneurysms.
    Wiernicki I; Safranow K; Baranowska-Bosiacka I; Piatek J; Gutowski P
    J Vasc Surg; 2010 Sep; 52(3):691-6. PubMed ID: 20570470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary Excretion of
    Deen CPJ; van der Veen A; van Faassen M; Minović I; Gomes-Neto AW; Geleijnse JM; Borgonjen-van den Berg KJ; Kema IP; Bakker SJL
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31726722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.
    Pihlstrøm H; Dahle DO; Mjøen G; Pilz S; März W; Abedini S; Holme I; Fellström B; Jardine AG; Holdaas H
    Transplantation; 2015 Feb; 99(2):351-9. PubMed ID: 25594550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of depression on long-term outcome after renal transplantation: a prospective cohort study.
    Zelle DM; Dorland HF; Rosmalen JG; Corpeleijn E; Gans RO; Homan van der Heide JJ; van Son WJ; Navis G; Bakker SJ
    Transplantation; 2012 Nov; 94(10):1033-40. PubMed ID: 23064656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal sulfate reabsorption in healthy individuals and renal transplant recipients.
    Post A; Minović I; van den Berg E; Eggersdorfer ML; Navis GJ; Geleijnse JM; Gans ROB; van Goor H; Struck J; Franssen CFM; Kema IP; Bakker SJL
    Physiol Rep; 2018 Apr; 6(8):e13670. PubMed ID: 29671959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Plasma Haptoglobin Level as a Potential Marker for Poor Prognosis in Acute Cerebral Infarction.
    Zhang T; Xiang L
    Eur Neurol; 2018; 79(3-4):154-160. PubMed ID: 29518787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of haptoglobin concentration in serum during the early phase of acute myocardial infarction.
    Bernard DR; Langlois MR; Delanghe JR; De Buyzere ML
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):85-8. PubMed ID: 9056748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haptoglobin 2-2 Phenotype Is Associated With Increased Acute Kidney Injury After Elective Cardiac Surgery in Patients With Diabetes Mellitus.
    Feng C; Naik BI; Xin W; Ma JZ; Scalzo DC; Thammishetti S; Thiele RH; Zuo Z; Raphael J
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor haptoglobin phenotype determines outcome following liver transplantation.
    Speeckaert R; Van Vlierberghe H; Troisi R; De Bacquer D; Speeckaert MM; De Buyzere ML; Claeys L; de Hemptinne B; Delanghe JR
    Transpl Int; 2011 Jun; 24(6):619-26. PubMed ID: 21401731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory Markers and Outcomes in Kidney Transplant Recipients.
    Molnar MZ; Nagy K; Remport A; Tapolyai MB; Fülöp T; Kamal F; Kovesdy CP; Mucsi I; Mathe Z
    Transplantation; 2017 Sep; 101(9):2152-2164. PubMed ID: 27798514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcohol consumption, new onset of diabetes after transplantation, and all-cause mortality in renal transplant recipients.
    Zelle DM; Agarwal PK; Ramirez JL; van der Heide JJ; Corpeleijn E; Gans RO; Navis G; Bakker SJ
    Transplantation; 2011 Jul; 92(2):203-9. PubMed ID: 21685828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with increased arterial stiffness in renal transplant recipients.
    Strózecki P; Adamowicz A; Włodarczyk Z; Manitius J
    Med Sci Monit; 2010 Jun; 16(6):CR301-6. PubMed ID: 20512094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.